Abstract:Abstract Introduction: High sugar consumption promotes endogenous formation of advanced glycation end-products (AGEs), a heterogeneous class of molecules originated from non-enzymatic glycation between reducing sugars and free amino groups of proteins, nucleic acids, or lipids. AGEs accumulation in tissues has been linked to aging and diabetes complications. AGEs might also play an independent role in inflammation and development of cardiovascular disease (CVD). Exogenous dietary AGEs, due to excess intake of modern heat-treated foods, might act synergistically with endogenous AGEs, thus contributing to increase inflammation and CVD. A large amount of ingested AGEs reaches the colon, where they might affect gut microbial metabolism, for example, by acting as substrate for colonic bacterial fermentation, driving alterations of microbiota composition and of intestinal permeability. However in vitro and in vivo studies (animal and human) on the impact of AGEs on the gut microbiota are discordant. This study on mice aims to link the modulation of gut microbiota by AGEs-enriched diet (AGE-D) with metabolic and inflammatory markers. Materials and methods: C57BL/6 mice were randomly allocated into the following dietary regimens: Control (n = 24) and AGE-D (n = 20) for 22 weeks. AGE-D was prepared replacing casein (200 g/kg diet) by an equal amount of modified casein where 10% of arginine was glycated with MG-H1 (methylglyoxal 5-hydro-5-methylimidazolone) for a total of 4 μmol of MG-H1 per g of diet. Faeces were collected using metabolic cages (18 h starving) at week 0, 11 and 22 for fecal DNA extraction and 16SrRNA analysis through Illumina MiSeq using V3-V4 targeted primers. After 22 weeks of dietary manipulation, mice were sacrificed, plasma and organ lipid profiles and serum metabolic and inflammatory profiles were determined. Results and discussion: AGE-D caused a significant reduction in the blood levels of two important components of the incretin system, GIP and GLP-1, when compared to control diet, suggestive of unbalance in the incretin-insulin axis. AGE-D exposure was associated with a significant increase in systemic concentrations of inflammatory cytokines, e.g. IL-1β and IL-17, and PAI-1, which has been suggested as both reliable marker and critical mediator of cellular senescence. We will present how AGEs impact on microbiome community structure and correlate changes in gut microbiota with GIP and GLP-1 levels. Conclusions: AGEs, characteristic of modern processed foods, appear to impact on the incretin-insulin axis, a key regulator of metabolic disease risk. Diets rich in AGEs may mediate these physiological effects at least in part, by reshaping intestinal microbiota structure.

Accumulation And Effects Of Dietary Advanced Glycation End Products On The Gastrointestinal Tract In Rats

Protein-bound AGEs Derived from Methylglyoxal Induce Pro-Inflammatory Response and Barrier Integrity Damage in Epithelial Cells by Disrupting the Retinol Metabolism

Dietary Advanced Glycation End Products Modify Gut Microbial Composition and Partially Increase Colon Permeability in Rats

Parallel Generation of Extra Advanced Glycation End-Products During Co-Digestion of Whey Proteins and Α-Dicarbonyls in a Simulated Gastrointestinal Model.

The fate of dietary advanced glycation end products in the body: from oral intake to excretion

Advanced glycation end products in food and their effects on intestinal tract

Antioxidant Balance And Accumulation Of Advanced Glycation End Products After The Consumption Of Standard Diets Including Maillard Reaction Products From Silver Carp Peptides

Effect of Glycation Derived from Α-Dicarbonyl Compounds on the in Vitro Digestibility of Ovalbumin: Tracing of Advanced Glycation End-Products and Immuno-Active Peptides

Advanced Glycation End Products and Food

Advanced Glycation End-Products and Their Effects on Gut Health

Long-term ingestion of -lactoglobulin-bound AGEs induces colonic inflammation by modulating RAGE (TLR4)/MYD88/NF-xB signaling pathway and gut microbiota in mice

Microbiome-Metabolomics Analysis of the Impacts of Long-Term Dietary Advanced-Glycation-End-Product Consumption on C57BL/6 Mouse Fecal Microbiota and Metabolites.

Water-Soluble Advanced Glycation End Products from Bread Crust Cause Oxidative Damage to Human Kidney Tubular Epithelial Cells

Generation of advanced glycation end products from glycated protein or fructose/glyoxal-protein adducts under in vitro simulated gastrointestinal digestion

Research Progress on the Effects of Dietary Advanced Glycation End Products on Intestinal Flora and Metabolic Disease

Advanced glycation end products (AGEs) in metabolic disease: linking diet, inflammation and microbiota

Selective Transportation and Energy Homeostasis Regulation of Dietary Advanced Glycation End-Products in Human Intestinal Caco-2 Cells.

Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits

Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review

Effect of Glycation Derived from Α-Dicarbonyl Compounds on the in Vitro Digestibility of Β-Casein and Β-Lactoglobulin: A Model Study with Glyoxal, Methylglyoxal and Butanedione.

Accumulation of Tissue Advanced Glycation End Products Correlated with Glucose Exposure Dose and Associated with Cardiovascular Morbidity in Patients on Peritoneal Dialysis